Eli Lilly and Company
@tauvidreadertraining.com
Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad) https://t.co/oXewUD8FZI
Eli Lilly and Company's Company Logos
Eli Lilly and Company's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D31710
Thunderbird
211, 23, 16
2, 86, 45
0, 89, 92, 17
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#101010
Cod Gray
16, 16, 16
0, 0, 6
0, 0, 0, 94
About Eli Lilly and Company
**Brand Description for TAUVID by Eli Lilly**
TAUVID, developed by Eli Lilly, is a diagnostic radiopharmaceutical designed for positron emission tomography (PET) imaging of the brain. It is specifically indicated for estimating the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients experiencing cognitive impairment during Alzheimer’s disease (AD) evaluations. TAUVID is supplied in multidose vials containing flortaucipir F 18, with concentrations ranging from 300 MBq/mL to 3700 MBq/mL.
While TAUVID plays a critical role in assessing neurodegenerative conditions, it is important to note that it does not target β-amyloid, a key element in diagnosing AD. Additionally, it is not approved for evaluating patients with chronic traumatic encephalopathy (CTE). Common adverse reactions may include headache, injection site pain, and increased blood pressure. Ensuring the safe use of TAUVID is emphasized, particularly regarding radiation exposure for patients and healthcare professionals. For comprehensive prescribing details and precautions, refer to the full prescribing information.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
